Patient follow-up and care after first-line treatment for prostate cancer

Some of the most interesting data on the management of prostate cancer seem to be coming out of Australia in recent years — and the newly reported data from the ProCare trial is a case in point. … READ MORE …

An unfortunately misleading statement in the AFP

Back in 2014, the American Cancer Society (ACS) issued a really rather thorough set of guidelines on the long-term management of survivors after initial treatment for prostate cancer. … READ MORE …

ASCO endorses ACS’s prostate cancer survivorship guidelines

In June last year the American Cancer Society (ACS) published the first-ever set of long-term care guidelines for prostate cancer survivors. The “New” Prostate Cancer InfoLink addressed and discussed those guidelines at the time of their publication. … READ MORE …

ACS issues new prostate cancer survivorship care guidelines

As long-time readers of this column will be aware, The “New” Prostate Cancer InfoLink has been less than enthused by some of the attitudes of the American Cancer Society (ACS) when it comes to education of physicians and patients about prostate cancer. However, praise is important when praise is due! … READ MORE …

“Survivorship is not a passive sport”

Some readers of this blog may get some insights by reading a blogpost on the CancerNetwork web site with the above title. … READ MORE …

Are survivorship care plans actually effective?

The “New” Prostate Cancer InfoLink has recently been arguing that prostate cancer patients who receive definitive treatment for their prostate cancer with curative intent need follow-up “survivorship care plans” or SCPs to be help them to optimize their recovery after treatment and their consequent quality of life. … READ MORE …

Follow-up to earlier commentary on the Michigan Prostate Cancer Survivor study

Late last week we commented briefly on a paper (by Darwish-Yassine et al.) entitled “Evaluating long-term patient centered outcomes following prostate cancer treatment: findings from the Michigan Prostate Cancer Survivor study.” … READ MORE …